Global Recombinant Proteins Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01245327

Publication Date:

January 4, 2024

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Recombinant Proteins market size was valued at US$ 954.5 million in 2023. With growing demand in downstream market, the Recombinant Proteins is forecast to a readjusted size of US$ 2317.1 million by 2030 with a CAGR of 13.5% during review period.
The research report highlights the growth potential of the global Recombinant Proteins market. Recombinant Proteins are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Recombinant Proteins. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Recombinant Proteins market.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
Key Features:
The report on Recombinant Proteins market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Recombinant Proteins market. It may include historical data, market segmentation by Type (e.g., Hormones, Growth Factors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Recombinant Proteins market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Recombinant Proteins market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Recombinant Proteins industry. This include advancements in Recombinant Proteins technology, Recombinant Proteins new entrants, Recombinant Proteins new investment, and other innovations that are shaping the future of Recombinant Proteins.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Recombinant Proteins market. It includes factors influencing customer ' purchasing decisions, preferences for Recombinant Proteins product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Recombinant Proteins market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Recombinant Proteins market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Recombinant Proteins market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Recombinant Proteins industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Recombinant Proteins market.
Market Segmentation:
Recombinant Proteins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segmentation by application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Proteins Market Size 2019-2030
2.1.2 Recombinant Proteins Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Recombinant Proteins Segment by Type
2.2.1 Hormones
2.2.2 Growth Factors
2.2.3 Cytokines
2.2.4 Plasma Protein Factor
2.2.5 Recombinant Metabolic Enzymes
2.2.6 Immune Checkpoint Regulators
2.2.7 Others
2.3 Recombinant Proteins Market Size by Type
2.3.1 Recombinant Proteins Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Recombinant Proteins Market Size Market Share by Type (2019-2024)
2.4 Recombinant Proteins Segment by Application
2.4.1 Biopharmaceutical Companies
2.4.2 Academic and Research Institutes
2.4.3 Contract Research Organizations
2.5 Recombinant Proteins Market Size by Application
2.5.1 Recombinant Proteins Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Recombinant Proteins Market Size Market Share by Application (2019-2024)
3 Recombinant Proteins Market Size by Player
3.1 Recombinant Proteins Market Size Market Share by Players
3.1.1 Global Recombinant Proteins Revenue by Players (2019-2024)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Proteins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Proteins by Regions
4.1 Recombinant Proteins Market Size by Regions (2019-2024)
4.2 Americas Recombinant Proteins Market Size Growth (2019-2024)
4.3 APAC Recombinant Proteins Market Size Growth (2019-2024)
4.4 Europe Recombinant Proteins Market Size Growth (2019-2024)
4.5 Middle East & Africa Recombinant Proteins Market Size Growth (2019-2024)
5 Americas
5.1 Americas Recombinant Proteins Market Size by Country (2019-2024)
5.2 Americas Recombinant Proteins Market Size by Type (2019-2024)
5.3 Americas Recombinant Proteins Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Proteins Market Size by Region (2019-2024)
6.2 APAC Recombinant Proteins Market Size by Type (2019-2024)
6.3 APAC Recombinant Proteins Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Proteins by Country (2019-2024)
7.2 Europe Recombinant Proteins Market Size by Type (2019-2024)
7.3 Europe Recombinant Proteins Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Proteins by Region (2019-2024)
8.2 Middle East & Africa Recombinant Proteins Market Size by Type (2019-2024)
8.3 Middle East & Africa Recombinant Proteins Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Proteins Market Forecast
10.1 Global Recombinant Proteins Forecast by Regions (2025-2030)
10.1.1 Global Recombinant Proteins Forecast by Regions (2025-2030)
10.1.2 Americas Recombinant Proteins Forecast
10.1.3 APAC Recombinant Proteins Forecast
10.1.4 Europe Recombinant Proteins Forecast
10.1.5 Middle East & Africa Recombinant Proteins Forecast
10.2 Americas Recombinant Proteins Forecast by Country (2025-2030)
10.2.1 United States Recombinant Proteins Market Forecast
10.2.2 Canada Recombinant Proteins Market Forecast
10.2.3 Mexico Recombinant Proteins Market Forecast
10.2.4 Brazil Recombinant Proteins Market Forecast
10.3 APAC Recombinant Proteins Forecast by Region (2025-2030)
10.3.1 China Recombinant Proteins Market Forecast
10.3.2 Japan Recombinant Proteins Market Forecast
10.3.3 Korea Recombinant Proteins Market Forecast
10.3.4 Southeast Asia Recombinant Proteins Market Forecast
10.3.5 India Recombinant Proteins Market Forecast
10.3.6 Australia Recombinant Proteins Market Forecast
10.4 Europe Recombinant Proteins Forecast by Country (2025-2030)
10.4.1 Germany Recombinant Proteins Market Forecast
10.4.2 France Recombinant Proteins Market Forecast
10.4.3 UK Recombinant Proteins Market Forecast
10.4.4 Italy Recombinant Proteins Market Forecast
10.4.5 Russia Recombinant Proteins Market Forecast
10.5 Middle East & Africa Recombinant Proteins Forecast by Region (2025-2030)
10.5.1 Egypt Recombinant Proteins Market Forecast
10.5.2 South Africa Recombinant Proteins Market Forecast
10.5.3 Israel Recombinant Proteins Market Forecast
10.5.4 Turkey Recombinant Proteins Market Forecast
10.5.5 GCC Countries Recombinant Proteins Market Forecast
10.6 Global Recombinant Proteins Forecast by Type (2025-2030)
10.7 Global Recombinant Proteins Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Information
11.1.2 Bio-Techne Corporation Recombinant Proteins Product Offered
11.1.3 Bio-Techne Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bio-Techne Corporation Main Business Overview
11.1.5 Bio-Techne Corporation Latest Developments
11.2 Abcam PLC
11.2.1 Abcam PLC Company Information
11.2.2 Abcam PLC Recombinant Proteins Product Offered
11.2.3 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abcam PLC Main Business Overview
11.2.5 Abcam PLC Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Recombinant Proteins Product Offered
11.3.3 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Information
11.4.2 Miltenyi Biotec Recombinant Proteins Product Offered
11.4.3 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Miltenyi Biotec Main Business Overview
11.4.5 Miltenyi Biotec Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific Recombinant Proteins Product Offered
11.5.3 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 ACROBiosystems
11.6.1 ACROBiosystems Company Information
11.6.2 ACROBiosystems Recombinant Proteins Product Offered
11.6.3 ACROBiosystems Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ACROBiosystems Main Business Overview
11.6.5 ACROBiosystems Latest Developments
11.7 Sino Biological
11.7.1 Sino Biological Company Information
11.7.2 Sino Biological Recombinant Proteins Product Offered
11.7.3 Sino Biological Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sino Biological Main Business Overview
11.7.5 Sino Biological Latest Developments
11.8 Cytiva
11.8.1 Cytiva Company Information
11.8.2 Cytiva Recombinant Proteins Product Offered
11.8.3 Cytiva Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cytiva Main Business Overview
11.8.5 Cytiva Latest Developments
11.9 Eurogentec
11.9.1 Eurogentec Company Information
11.9.2 Eurogentec Recombinant Proteins Product Offered
11.9.3 Eurogentec Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eurogentec Main Business Overview
11.9.5 Eurogentec Latest Developments
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Information
11.10.2 GenScript Biotech Corporation Recombinant Proteins Product Offered
11.10.3 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GenScript Biotech Corporation Main Business Overview
11.10.5 GenScript Biotech Corporation Latest Developments
11.11 Reprocell
11.11.1 Reprocell Company Information
11.11.2 Reprocell Recombinant Proteins Product Offered
11.11.3 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Reprocell Main Business Overview
11.11.5 Reprocell Latest Developments
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Information
11.12.2 BPS Bioscience Recombinant Proteins Product Offered
11.12.3 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BPS Bioscience Main Business Overview
11.12.5 BPS Bioscience Latest Developments
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Information
11.13.2 Abnova Corporation Recombinant Proteins Product Offered
11.13.3 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Abnova Corporation Main Business Overview
11.13.5 Abnova Corporation Latest Developments
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Information
11.14.2 ProSpec Tany TechnoGene Recombinant Proteins Product Offered
11.14.3 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 ProSpec Tany TechnoGene Main Business Overview
11.14.5 ProSpec Tany TechnoGene Latest Developments
11.15 Ajinomoto
11.15.1 Ajinomoto Company Information
11.15.2 Ajinomoto Recombinant Proteins Product Offered
11.15.3 Ajinomoto Recombinant Proteins Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Ajinomoto Main Business Overview
11.15.5 Ajinomoto Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂